Leval 20
Selective, strong inhibitor of Phosphodiesterase type 5 (PDE5) indicated for the treatment of patients with pulmonary arterial hypertension. By vasodilating the pulmonary vascular bed it improves exercise ability and delays clinical worsening
Therapeutic Area
Pulmonary hypertension
Active Ingredient
Tadalafil
Line
Pulmonary hypertension
Dosage forms
20 mg tablets x 30 and 60 units
